A randomized, double‐blind, placebo‐controlled study on long‐term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long‐Term
ASP1941
Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study
2015 ◽
Vol 17
(2)
◽
pp. 152-160
◽
Keyword(s):